The Enterprise Value as of November 2024 (TTM) for Cybin Inc. (CYBN) is 98.00M

According to Cybin Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 98.00M. This represents a change of -99.01% compared to the average of 9.89B of the last 4 quarters.

Cybin Inc. (CYBN) Historical Enterprise Value (quarterly & annually)

How has CYBN Enterprise Value performed in the past?

The mean historical Enterprise Value of Cybin Inc. over the last ten years is 2.00B. The current 98.00M Enterprise Value has changed 390.10% with respect to the historical average. Over the past ten years (40 quarters), CYBN's Enterprise Value was at its highest in in the September 2021 quarter at 17.45B. The Enterprise Value was at its lowest in in the December 2019 quarter at 0.

Cybin Inc. (CYBN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Cybin Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cybin Inc. (CYBN) Average Enterprise Value

How has CYBN Enterprise Value performed in the past?

The current Enterprise Value of Cybin Inc. (CYBN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Cybin Inc. (CYBN) Enterprise Value vs. Peers

How is CYBN’s Enterprise Value compared to its peers?

Cybin Inc.’s Enterprise Value is less than Mind Medicine (MindMed) Inc. (225.51M), greater than Seelos Therapeutics, Inc. (10.40M), less than GH Research PLC (329.85M), greater than Awakn Life Sciences Corp. (3.92M), less than Atai Life Sciences N.V. (164.47M), greater than Fortress Biotech, Inc. (59.91M), greater than Bio-Path Holdings, Inc. (-340985.00), greater than Vaccinex, Inc. (8.95M), less than Eliem Therapeutics, Inc. (119.64M), less than Opthea Limited (656.58M), greater than Molecular Partners AG (57.72M), less than Edgewise Therapeutics, Inc. (3.19B), greater than iTeos Therapeutics, Inc. (82.02M), greater than Immix Biopharma, Inc. (20.49M), greater than CNS Pharmaceuticals, Inc. (2.61M), less than VectivBio Holding AG (848.58M), greater than Zura Bio Limited (90.25M), greater than ZyVersa Therapeutics, Inc. (1.84M),

Build a custom stock screener for Cybin Inc. (CYBN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cybin Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cybin Inc. (CYBN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cybin Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.